Animal NDC 13985-520-02 Iron Hydrogenated Dextran

Iron

Animal Product Information

Field Name Field Value
Animal NDC Code 13985-520-02
Proprietary Name Iron Hydrogenated Dextran What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Iron What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Mwi Veterinary Supply, Inc.
Product Type Otc Animal Drug
Usage Information
    For the prevention and treatment of anemia due to iron deficiency in nursing piglets. Iron deficiency anemia occurs commonly in the nursing piglets, often within the first few days following birth. As body size and blood volume increase rapidly from the first few days following birth, hemoglobin levels in the blood fall due to diminishing iron reserves which cannot be replaced adequately from iron in the sow's milk. Thus, the need for a readily available outside source of iron is apparent. Without this additional iron many newborn pigs may develop anemia within the first few days of life. Anemia retards growth and lowers the body defenses against disease; scours, pneumonia, and other conditions may develop. Death from anemia or infections may occur, sometimes destroying entire litters.
Active Ingredient(s)
  • Iron
Marketing Category NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NADA138255 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Iron Hydrogenated Dextran Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Description



100 mg/mL

For Prevention and Treatment of Iron Deficiency Anemia in Nursing Piglets

Approved by FDA under NADA # 138-255

NOT FOR HUMAN USE

KEEP OUT OF REACH OF CHILDREN

DESCRIPTION: IRON HYDROGENATED DEXTRAN INJECTION is a sterile solution containing 100 mg of elemental iron per mL, stabilized with a low molecular weight hydrogenated dextran and 0.5% phenol as a preservative.


Indications



For the prevention and treatment of anemia due to iron deficiency in nursing piglets. Iron deficiency anemia occurs commonly in the nursing piglets, often within the first few days following birth. As body size and blood volume increase rapidly from the first few days following birth, hemoglobin levels in the blood fall due to diminishing iron reserves which cannot be replaced adequately from iron in the sow's milk. Thus, the need for a readily available outside source of iron is apparent. Without this additional iron many newborn pigs may develop anemia within the first few days of life. Anemia retards growth and lowers the body defenses against disease; scours, pneumonia, and other conditions may develop. Death from anemia or infections may occur, sometimes destroying entire litters.


Dosage



For intramuscular injection only.

For Prevention of iron deficiency anemia, administer 1 mL (100 mg iron) at 2 to 4 days of age.

For Treatment of iron deficiency anemia, administer 1 mL (100 mg iron). Treatment may be repeated in 10 days.

DIRECTIONS FOR USE

Use a clean, sterile syringe and needle (20 gauge ½” needle); and ensure the injection site is clean and dry. Administer intramuscularly into the
back of the ham muscle to a depth of approximately ½ inch (see diagram below). Apply tension to the skin at the injection site by pulling skin and fat downward withpressure from the thumb or fingers.


Precautions



If disease or abnormal condition is suspected, consult veterinarian before administration.


Warnings



WARNINGS WITHDRAWAL PERIODS: No withdrawal period is required when used according to labeling.

ANIMAL SAFETY WARNINGS: Clinical signs associated with iron toxicity in piglets include convulsion, respiratory distress (tachypnoea, dyspnea) injection site reactions (inflammation, infection or necrosis), muscle tremors or weakness, prostration, and death. There is increased risk for iron toxicity in piglets born to sows with vitamin E/ selenium deficiencies.


Side Effects



Occasionally nursing piglets may exhibit a reaction to iron injection, clinically characterized by prostration and muscular weakness. In extreme cases, death may result.

NOTICE: The intramuscular injection of organic iron preparations into pigs beyond 4 weeks of age may cause staining of muscle tissue.


How Supplied



100 mL and 250 mL multiple dose vials.

Each mL of sterile solution contains 100 mg of elemental iron stabilized with a low molecular weight hydrogenated dextran and 0.5% phenol as a preservative.


Storage And Handling



Store between 15° and 30°C (59° - 86°F).
Protect from freezing.
Use within 18 months of first puncture and
puncture a maximum of 200 times.


Questions/Comments



Contact Sparhawk Laboratories Inc. at 1-800-255-6388 or sparhawklabs.com. To report side effects, contact Sparhawk Laboratories Inc. at 1-800-255-6388. For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or
http://www.fda.gov/reportanimalae.


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.